Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

FDA Approves Lacosamide for Pediatric Partial-Onset Seizures

FDA Approves Lacosamide for Pediatric Partial-Onset Seizures

By

The FDA has approved lacosamide for treating pediatric patients with partial-onset seizures.

Novel Alzheimer Drug Wins FDA Fast-Track Designation

Novel Alzheimer Drug Wins FDA Fast-Track Designation

By

The FDA has granted Fast Track status to an investigational agent for the treatment of Alzheimer disease.

Switch to Alemtuzumab Reduces MS Disease Activity

Switch to Alemtuzumab Reduces MS Disease Activity

By

Patients experienced reduced disease activity when switched to alemtuzumab.

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

By

There are no FDA-approved MS therapies for the pediatric population.

Gabapentin, Opioid Combo May Increase Risk of Opioid-Related Death

Gabapentin, Opioid Combo May Increase Risk of Opioid-Related Death

By

There is a higher risk for opioid-related death in patients taking concomitant prescription opioids and gabapentin.

More Articles by Diana Ernst, RPh

Sign Up for Free e-newsletters

CME Focus